Tacrolimus measurement by microparticle enzyme immunoassay II
| dc.contributor.author | Taylor, P. | |
| dc.contributor.author | Morris, R. | |
| dc.date.issued | 2003 | |
| dc.description.statementofresponsibility | PJ Taylor and RG Morris | |
| dc.description.uri | http://www.ncbi.nlm.nih.gov/pubmed/12766549 | |
| dc.identifier.citation | Therapeutic Drug Monitoring, 2003; 25(3):259-260 | |
| dc.identifier.doi | 10.1097/00007691-200306000-00001 | |
| dc.identifier.issn | 0163-4356 | |
| dc.identifier.issn | 1536-3694 | |
| dc.identifier.uri | http://hdl.handle.net/2440/33522 | |
| dc.language.iso | en | |
| dc.publisher | Lippincott Williams & Wilkins | |
| dc.source.uri | https://doi.org/10.1097/00007691-200306000-00001 | |
| dc.subject | Humans | |
| dc.subject | Tacrolimus | |
| dc.subject | Immunoenzyme Techniques | |
| dc.title | Tacrolimus measurement by microparticle enzyme immunoassay II | |
| dc.type | Journal article | |
| pubs.publication-status | Published |